Evaluation of hyperglycaemic response to intra-operative dexamethasone administration in patients undergoing elective intracranial surgery: A randomised, prospective study

BACKGROUND AND AIM: The glucocorticoid dexamethasone in a bolus dose of 8-10 mg followed by quarterly dose of 4 mg is commonly used during intracranial surgery so as to reduce oedema and vascular permeability. However, the detrimental hyperglycaemic effects of dexamethasone may override its potentia...

Descripción completa

Detalles Bibliográficos
Autores principales: Sethi, Rakesh, Naqash, Imtiaz A., Bajwa, Sukhminder Jit Singh, Dutta, Vikas, Ramzan, Altaf Umar, Zahoor, Syed Amir
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Medknow Publications & Media Pvt Ltd 2016
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4802961/
https://www.ncbi.nlm.nih.gov/pubmed/27057213
http://dx.doi.org/10.4103/1793-5482.177660

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4802961/
https://www.ncbi.nlm.nih.gov/pubmed/27057213
http://dx.doi.org/10.4103/1793-5482.177660

Ejemplares similares